Introduction
============

Atrial fibrillation (AF) is a modifiable risk factor of ischemic stroke, and 20% to 30% of ischemic stroke patients have AF diagnosed before, during, or after stroke events \[[@b1-jos-2018-03265]\]. In patients with AF, more than 60% of strokes could be prevented by use of an oral anticoagulant (OAC) \[[@b2-jos-2018-03265],[@b3-jos-2018-03265]\]. For ischemic stroke patients with permanent or paroxysmal AF, an OAC is generally indicated to prevent recurrent strokes \[[@b4-jos-2018-03265]\]. However, in real-world practice, reports have shown that a substantial proportion of AF patients who are eligible for OAC treatment remained untreated or inadequately treated by antiplatelet agents \[[@b5-jos-2018-03265]\].

Both permanent and paroxysmal AF are related to increased stroke risk and warrant anticoagulants treatment, but paroxysmal AF especially makes a big challenge in clinical practice \[[@b6-jos-2018-03265]\]. Some stroke patients may not have AF found on 12-lead electrocardiogram or even long-term cardiac monitoring during an index stroke hospitalization, but may have a history of transient paroxysmal AF. Transient paroxysmal AF may be easily overlooked if it is not clearly communicated by the patient or not clearly documented in accessible medical records.

We hypothesized that the ischemic stroke patients who had an untreated transient paroxysmal AF history that was overlooked and remained untreated during the index stroke hospitalization may have an increased recurrent stroke risk, as compared to stroke patients without AF. We performed this study to determine whether an unrecognized history of paroxysmal AF increased the 1-year recurrent stroke risk among ischemic stroke patients without AF identified at discharge.

Methods
=======

We conducted a retrospective nationwide cohort study using the Taiwan National Health Insurance Research Database (NHIRD) in the period from January 2001 to December 2012, using the 9th revision of the International Classification of Diseases (ICD-9). Inclusion criteria were: (1) patient ≥20 years old, (2) first episode of stroke hospitalization with a primary diagnosis of ischemic stroke (ICD-9 codes 433.X1, 434.X1, 436) in the study period, and (3) patient survived and had no AF diagnosis (ICD-9 code 42731) at discharge. Stroke hospitalization was defined as admission for inpatient service in any department in medical institutions, not including outpatient clinics or emergency department visits. Any stroke hospitalization with admission date more than 3 days apart from discharge date of a previous stroke hospitalization was defined as a new stroke hospitalization. We excluded patients who had no computed tomography or magnetic resonance imaging of brain during the index hospitalization or within 7 days prior to admission, because the diagnosis of ischemic stroke may be inaccurate without the confirmation of brain imaging. We also excluded patients who had used anticoagulant during the index hospitalization, because these patients may have recognized AF that was not recorded in the first five diagnoses in the discharge medical records. We further excluded patients with diagnosis of intracranial hemorrhage (ICD-9 codes 430.xx-432.xx), gastrointestinal hemorrhage (ICD-9 codes 578.xx), or hematuria (ICD-9 codes 599.70) before or during index stroke hospitalization, because these patients may be untreated with anticoagulants because they had history of major bleeding events, but not because their AF were "unrecognized." Prior diagnosis of AF was ascertained looking back from the stroke date to the beginning of 1997 since we used data starting from 1997. The median of the look-back period for an AF diagnosis was 11.2 years (interquartile range, 8.9 to 13.5). Included patients were categorized into two groups: unrecognized AF history and no AF. Patients with unrecognized AF history were defined as having had an AF diagnosis at least once during any hospitalization preceding the index stroke hospitalization or at least twice in the outpatient setting before the index stroke ([Figure 1](#f1-jos-2018-03265){ref-type="fig"}).

The primary endpoint was any recurrent stroke (ICD-9 430-434, 436), and secondary endpoints were any recurrent ischemic stroke (ICD-9 433.X1, 434.X1, 436), intracranial hemorrhage (ICD-9 430-432), and AF (ICD-9 427.31) within 1 year after discharge from the index stroke.

This study was approved by the Institutional Review Board of Chang Gung Memorial Hospital, Chiayi, Taiwan. This was a nationwide study that included all available and eligible patients. The individual's personal information in the databases were encrypted for privacy protection; therefore, the requirement of informed consent was waived.

Comorbidities before the index stroke for each case were extracted, including hypertension (ICD-9 401-405), ischemic heart disease (ICD-9 410-414), diabetes mellitus (ICD-9 250), dyslipidemia (ICD-9 272), prior stroke (ICD-9 430-434, 436-438), heart failure (ICD-9 428), peripheral vascular disease (ICD-9 443.9), chronic obstructive pulmonary disease (ICD-9 491, 492, 496), sleep apnea (ICD-9 327.23, 780.57), and chronic kidney disease (ICD-9 585, 403). Stroke severity was evaluated by the stroke severity index (SSI) (airway suctioning, bacterial sensitivity test, general ward stay, intensive care unit stay, nasogastric intubation, osmotherapy, and urinary catheterization), developed specifically to evaluate the severity of strokes in Taiwan NHIRD \[[@b7-jos-2018-03265]\].

Statistical analysis
--------------------

To mitigate differences of baseline characteristics between the two groups (unrecognized AF vs. no AF), we conducted propensity score matching. We performed logistic regression models for variables including sex, age, SSI, hypertension, ischemic heart disease, diabetes mellitus, dyslipidemia, prior stroke, heart failure, peripheral vascular disease, chronic obstructive pulmonary disease, sleep apnea, and chronic kidney disease for propensity score analysis and created a 1:2 matched pairs. The baseline characteristics of original and matched two groups were compared using standardized difference (SD). SD \>0.1 was considered as statistically significant difference between the two groups.

We employed the Cox regression for original cohort and stratified Cox regression for matched cohort to estimate the unadjusted and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of the group having unrecognized history of transient AF, with the group having no AF history as the reference. The model was adjusted for baseline age, sex, hypertension, diabetes mellitus, hyperlipidemia, ischemic heart disease, stroke history, chronic kidney disease, heart failure, chronic obstructive pulmonary disease, peripheral vascular disease, sleep apnea, and SSI. A 2-sided *P*\<0.05 were considered to be statistically significant.

The data were analyzed with SAS statistical software version 9.4 (SAS Institute Inc., Cary, NC, USA).

Results
=======

Among 203,489 ischemic stroke patients discharged alive without an AF diagnosis at discharge, 6,731 patients (3.3%) had an unrecognized history of transient AF before index stroke. In original cohort, patients with unrecognized history of transient AF were older, less likely to be men, more often having hypertension, ischemic heart disease, prior stroke history, chronic kidney disease, heart failure history, chronic obstructive pulmonary disease, less often having hyperlipidemia, and having more severe stroke symptoms than patients without AF ([Table 1](#t1-jos-2018-03265){ref-type="table"}). In matched cohort, the age, sex, stroke severity and comorbidities in the two groups had no significant difference ([Table 1](#t1-jos-2018-03265){ref-type="table"}).

During the 1-year follow-up period, patients with unrecognized AF history had higher risks of all recurrent stroke (\[original cohort: HR, 1.41; 95% CI, 1.30 to 1.53\], \[matched cohort: HR, 1.51; 95% CI, 1.37 to 1.68\]), recurrent ischemic stroke (\[original cohort: HR, 1.42; 95% CI, 1.30 to 1.55\], \[matched cohort: HR, 1.56; 95% CI, 1.40 to 1.74\]), and newly-detected AF (\[original cohort: HR, 11.3; 95% CI, 10.7 to 12.0\], \[matched cohort: HR, 9.66; 95% CI, 8.84 to 10.55\]) after adjustment of relevant covariates. There was a non-significant trend of increased risk for hemorrhagic stroke (\[original cohort: HR, 1.29; 95% CI, 0.96 to 1.72\], \[matched cohort: HR, 1.10; 95% CI, 0.79 to 1.54\]), when compared to patients without AF ([Table 2](#t2-jos-2018-03265){ref-type="table"}). For all endpoints, there is no difference in stratified Cox regression.

Before the index stroke, 907 of patients (13.5%) with unrecognized AF and 1,909 patients (1%) with no AF had used anticoagulants. After discharge from the index stroke, 859 of patients (14.76%) with unrecognized AF and 243 of patients (1.85%) with no AF were prescribed anticoagulants.

Discussion
==========

This nationwide study showed that among ischemic stroke patients without AF diagnosed at discharge, 3.7% actually had an unrecognized history of transient AF, and these patients had higher risks of recurrent strokes, recurrent ischemic strokes, and AF at 1-year follow-up compared to ischemic stroke patients without AF.

OACs prevent primary strokes in AF patients and prevent recurrent strokes in ischemic stroke patients with AF \[[@b1-jos-2018-03265]\]. However, 25% to 40% of AF is paroxysmal and clinically silent \[[@b8-jos-2018-03265]\]. As such it can be a major challenge to detect paroxysmal AF in ischemic stroke patients. Our study shows that some hospitalized ischemic stroke patients may have previous history of untreated transient paroxysmal AF that remains unrecognized at the time of hospital discharge, thereby exposing these patients to significantly higher future risk of recurrent stroke. For these patients, use of antiplatelet drugs would be less effective than anticoagulants in the prevention of recurrent strokes.

In Taiwan, there are some situations in that transient AF may be diagnosed but not treated with anticoagulants. First, when the transient AF is diagnosed when the patient has no or only one vascular risk factor. Second, when the patient has plan to do surgery or invasive procedure recently. Third, when the patient has recent bleeding events or major bleeding history. Fourth, when AF is diagnosed in emergency department or in routine health examination, and the patient is not referred to cardiovascular or other adequate outpatient department for follow-up and further management.

There are some possible causes of unrecognized AF history among discharged ischemic stroke patients. First, for patients with an index ischemic stroke mechanism presumed to be noncardioembolic, and a normal electrocardiogram during that hospitalization, the possibility of pre-admission history of transient AF may be overlooked. Second, without the ready availability of preceding outpatient medical record information, clinicians may be unaware of an untreated pre-admission transient episode(s) of AF. This issue may be especially challenging within uncoordinated healthcare systems where patients are hospitalized at tertiary care facilities that are outside of their routine primary health care delivery network.

We suggest that once AF has been detected it should be integrated into a patient's electronic health profile and an autonomic alert system could be activated in certain key clinical scenarios, such as stroke. Moreover, the evaluation of possible pre-admission AF history could be included as an item on a checklist of discharge preparation following an ischemic stroke hospitalization.

There were some limitations. Most importantly, we relied on ICD-9-CM to ascertain AF, and it is possible that some cases of unrecognized AF represented recognized but simply undocumented AF. However, most of these patients would receive anticoagulant treatments, and we had excluded the patients who received anticoagulants during the index hospitalization or for more than 30 days before the index hospitalization. Second, we did not know the specific ischemic stroke subtypes of these patients. Also, we were unable to analyze the possible reasons for why prior AF history remained unrecognized at the time of discharge from an ischemic stroke hospitalization because of the limitations of the insurance database.

Conclusions
===========

In conclusion, an unrecognized history of transient AF was associated with higher risks of recurrent stroke among ischemic stroke patients. Careful history review to uncover a paroxysmal AF history are important for ischemic stroke patients.
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###### 

Baseline characteristics of original and matched groups without AF and with unrecognized AF

  Demographic characteristic                 Original       Matched                                                    
  ------------------------------------------ -------------- ---------------- ---------- -------------- --------------- --------
  Male sex                                   3,481 (51.7)   116,644 (59.3)   0.1527     3,479 (51.7)   6,969 (51.8)    0.0016
  Age (yr)                                   76.9±9.7       67.8±12.7        0.7982     76.8±9.7       77.1±9.6        0.0302
  Comorbidity                                                                                                          
   Hypertension                              6,035 (89.7)   158,660 (80.6)   0.2558     6,031 (89.7)   12,219 (90.8)   0.0393
   Diabetes                                  3,024 (44.9)   87,218 (44.3)    0.0120     3,024 (45.0)   6,061 (45.1)    0.0019
   Hyperlipidemia                            2,618 (38.9)   89,500 (45.5)    --0.1338   2,618 (38.9)   5,442 (40.5)    0.0313
   Ischemic heart disease                    4,755 (70.6)   58,901 (29.9)    0.8914     4,751 (70.6)   9,843 (73.2)    0.0564
   Prior stroke/transient ischemic attacks   2,072 (30.8)   36,662 (18.6)    0.2845     2,070 (30.8)   4,251 (31.6)    0.0178
   Chronic kidney disease                    844 (12.5)     11,350 (5.8)     0.2364     842 (12.5)     1,513 (11.3)    0.0393
   Heart failure                             3,316 (49.3)   18,204 (9.3)     0.9793     3,312 (49.1)   6,401 (47.6)    0.0332
   Chronic obstructive pulmonary disease     2,614 (38.8)   36,683 (18.6)    0.4577     2,610 (38.8)   5,216 (38.8)    0.0006
   Peripheral vascular disease               213 (3.2)      4,156 (2.1)      0.0657     212 (3.24)     346 (2.6)       0.0348
   Sleep apnea                               22 (0.3)       504 (0.3)        0.0131     22 (0.3)       38 (0.3)        0.0081
  Stroke severity index                                                                                                
   Mild                                      4,026 (57.4)   155,745 (79.2)   --0.4296   4,026 (59.9)   8,267 (61.5)    0.0327
   Moderate                                  1,071 (16.5)   24,401 (12.4)    0.1008     1,071 (15.9)   2,109 (15.7)    0.0067
   Severe                                    1,634 (26.1)   16,612 (8.4)     0.4382     1,630 (24.2)   3,078 (22.9)    0.0319

Values are presented as number (%) or mean±standard deviation.

AF, atrial fibrillation.

###### 

HR^[\*](#tfn1-jos-2018-03265){ref-type="table-fn"}^ of primary and secondary outcomes at 1 year in unrecognized AF vs. no AF groups

  Variable                                        Crude HR (95% CI)      *P*       Adjusted HR (95% CI)                                                   *P*
  ----------------------------------------------- ---------------------- --------- ---------------------------------------------------------------------- ---------
  Original cohort                                                                                                                                         
   Recurrent stroke                               1.53 (1.42--1.66)      \<0.001   1.41 (1.30--1.53)^[†](#tfn2-jos-2018-03265){ref-type="table-fn"}^      \<0.001
   Secondary outcome                                                                                                                                      
    Ischemic stroke                               1.54 (1.42--1.68)      \<0.001   1.42 (1.30--1.55)^[†](#tfn2-jos-2018-03265){ref-type="table-fn"}^      \<0.001
    Intracranial hemorrhage                       1.40 (1.06--1.84)      0.018     1.29 (0.96--1.72)^[†](#tfn2-jos-2018-03265){ref-type="table-fn"}^      0.089
    AF documented within 1 year of index stroke   21.30 (21.20--23.45)   \<0.001   11.32 (10.67--12.02)^[†](#tfn2-jos-2018-03265){ref-type="table-fn"}^   \<0.001
  Matched cohort                                                                                                                                          
   Recurrent stroke                               1.50 (1.35--1.66)      \<0.001   1.51 (1.37--1.68)                                                      \<0.001
   Secondary outcome                                                                                                                                      
    Ischemic stroke                               1.55 (1.39--1.72)      \<0.001   1.56 (1.40--1.74)                                                      \<0.001
    Intracranial hemorrhage                       1.11 (0.79--1.55)      0.558     1.10 (0.79--1.54)                                                      0.581
    AF documented within 1 year of index stroke   9.63 (8.81--10.52)     \<0.001   9.66 (8.84--10.55)                                                     \<0.001

HR, hazard ratio; AF, atrial fibrillation; CI, confidence interval.

We employed the Cox regression for original cohort and stratified Cox regression for matched cohort to estimate the crude and adjusted HR and 95% CIs of the group having unrecognized history of transient AF, with the group having no AF history as the reference;

Model was adjusted for age, sex, hypertension, diabetes, hyperlipidemia, ischemic heart disease, prior stroke, chronic kidney disease, heart failure, chronic obstructive pulmonary disease, peripheral vascular disease, sleep apnea, and stroke severity index.
